Orchestra BioMed Holdings's total assets for Q4 2024 were $76.17M, an increase of 1.13% from the previous quarter. OBIO total liabilities were $43.22M for the fiscal quarter, a 48.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.